Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Dynamic PET-facilitated modeling and high-dose rifampin regimens for Staphylococcus aureus orthopedic implant-associated infections.

  • Authors : Gordon O; Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Subjects: Rifampin*/Rifampin*/Rifampin*/pharmacokinetics ; Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Staphylococcal Infections*/Staphylococcal Infections*/Staphylococcal Infections*/drug therapy

  • Source: Science translational medicine [Sci Transl Med] 2021 Dec; Vol. 13 (622), pp. eabl6851. Date of Electronic Publication: 2021 Dec 01.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication

Record details

×
Academic Journal

Noninvasive 11 C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis.

  • Authors : Tucker EW; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Subjects: Positron-Emission Tomography*; Carbon Radioisotopes/Carbon Radioisotopes/Carbon Radioisotopes/*chemistry ; Rifampin/Rifampin/Rifampin/*therapeutic use

  • Source: Science translational medicine [Sci Transl Med] 2018 Dec 05; Vol. 10 (470).Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication

Record details

×
Academic Journal

Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data.

  • Authors : Rifat D; Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.; Prideaux B

Subjects: Rifampin/Rifampin/Rifampin/*analogs & derivatives ; Rifampin/Rifampin/Rifampin/*pharmacokinetics ; Tuberculosis/Tuberculosis/Tuberculosis/*drug therapy

  • Source: Science translational medicine [Sci Transl Med] 2018 Apr 04; Vol. 10 (435).Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication

Record details

×
Academic Journal

The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.

  • Authors : Gagneux S; Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA 94305, USA. ; Long CD

Subjects: Drug Resistance, Multiple, Bacterial*; Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*pharmacology ; Mycobacterium tuberculosis/Mycobacterium tuberculosis/Mycobacterium tuberculosis/*drug effects

  • Source: Science (New York, N.Y.) [Science] 2006 Jun 30; Vol. 312 (5782), pp. 1944-6.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Academic Journal

Rifampicin inhibition of protein synthesis in mammalian cells.

Subjects: Protein Biosynthesis*; Liver/Liver/Liver/*drug effects ; Rifampin/Rifampin/Rifampin/*pharmacology

  • Source: Science (New York, N.Y.) [Science] 1978 Apr 28; Vol. 200 (4340), pp. 432-4.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Academic Journal

Inhibitors of DNA polymerases of murine leukemia viruses: activity of ethidium bromide.

Subjects: DNA Nucleotidyltransferases/DNA Nucleotidyltransferases/DNA Nucleotidyltransferases/*antagonists & inhibitors ; Daunorubicin/Daunorubicin/Daunorubicin/*pharmacology ; Leukemia Virus, Murine/Leukemia Virus, Murine/Leukemia Virus, Murine/*drug effects

  • Source: Science (New York, N.Y.) [Science] 1971 Jul 30; Vol. 173 (3995), pp. 441-3.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Academic Journal

Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum.

Subjects: Amphotericin B/Amphotericin B/Amphotericin B/*pharmacology ; Antifungal Agents/Antifungal Agents/Antifungal Agents/*pharmacology ; Histoplasma/Histoplasma/Histoplasma/*drug effects

  • Source: Science (New York, N.Y.) [Science] 1972 Aug 25; Vol. 177 (4050), pp. 709-10.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
  • 1-10 of  114 results for ""Rifampin""